These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 33584287)

  • 21. Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II.
    Reinisch W; Sandborn WJ; Danese S; Hébuterne X; Kłopocka M; Tarabar D; Vaňásek T; Greguš M; Hellstern PA; Kim JS; Sparrow MP; Gorelick KJ; Hoy M; Goetsch M; Bliss C; Gupta C; Cataldi F; Vermeire S
    J Crohns Colitis; 2021 Jun; 15(6):938-949. PubMed ID: 33599720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease.
    Matsuoka K; Naganuma M; Hibi T; Tsubouchi H; Oketani K; Katsurabara T; Hojo S; Takenaka O; Kawano T; Imai T; Kanai T
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2180-2186. PubMed ID: 33599356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials.
    Tummala R; Abreu G; Pineda L; Michaels MA; Kalyani RN; Furie RA; Morand EF
    Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33597205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periodontitis and the outcome of atrial fibrillation ablation: Porphyromonas gingivalis is related to atrial fibrillation recurrence.
    Miyauchi S; Tokuyama T; Shintani T; Nishi H; Hamamoto Y; Ouhara K; Furusho H; Miyauchi M; Komatsuzawa H; Nakano Y
    J Cardiovasc Electrophysiol; 2021 May; 32(5):1240-1250. PubMed ID: 33590642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours.
    Vidal L; Victoria I; Gaba L; Martín MG; Brunet M; Colom H; Cortal M; Gómez-Ferrería M; Yeste-Velasco M; Perez A; Rodon J; Sohal DPS; Lizcano JM; Domènech C; Alfón J; Gascón P
    Eur J Cancer; 2021 Mar; 146():87-94. PubMed ID: 33588149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
    Zelniker TA; Ardissino M; Andreotti F; O'Donoghue ML; Yin O; Park JG; Murphy SA; Ruff CT; Lanz HJ; Antman EM; Braunwald E; Giugliano RP; Merlini PA
    Circulation; 2021 Feb; 143(7):673-684. PubMed ID: 33587659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The W101C
    Kayser A; Dittmann S; Šarić T; Mearini G; Verkerk AO; Schulze-Bahr E
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in Antiarrhythmic Drug Therapy.
    Saljic A; Heijman J; Dobrev D
    Drugs; 2023 Sep; 83(13):1147-1160. PubMed ID: 37540446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of
    Meyer KM; Malhotra N; Kwak JS; El Refaey M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Relevance of GIRK Channels in Heart Function.
    Campos-Ríos A; Rueda-Ruzafa L; Lamas JA
    Membranes (Basel); 2022 Nov; 12(11):. PubMed ID: 36363674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Antiarrhythmic Drugs for Atrial Fibrillation.
    Saljic A; Heijman J; Dobrev D
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological inhibition of acetylcholine-regulated potassium current (
    Linz B; Thostrup AH; Saljic A; Rombouts K; Hertel JN; Hohl M; Milnes J; Tfelt-Hansen J; Linz D; Jespersen T
    Heart Rhythm O2; 2022 Feb; 3(1):97-104. PubMed ID: 35243441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review.
    Papathanasiou KA; Giotaki SG; Vrachatis DA; Siasos G; Lambadiari V; Iliodromitis KE; Kossyvakis C; Kaoukis A; Raisakis K; Deftereos G; Papaioannou TG; Giannopoulos G; Avramides D; Deftereos SG
    Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of selective I
    Fenner MF; Carstensen H; Dalgas Nissen S; Melis Hesselkilde E; Scott Lunddahl C; Adler Hess Jensen M; Loft-Andersen AV; Sattler SM; Platonov P; El-Haou S; Jackson C; Tang R; Kirby R; Ford J; Schotten U; Milnes J; Svane Sørensen U; Jespersen T; Buhl R
    Br J Pharmacol; 2020 Aug; 177(16):3778-3794. PubMed ID: 32436234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the acetylcholine-regulated potassium current prevents transient apnea-related atrial arrhythmogenic changes in a porcine model.
    Norup Hertel J; Linz B; Isaksen J; Jerltorp K; Leonhardt C; Gottlieb L; Saljic A; Jespersen T; Linz D
    Heart Rhythm; 2024 May; 21(5):622-629. PubMed ID: 38280622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.
    van Hunnik A; Lau DH; Zeemering S; Kuiper M; Verheule S; Schotten U
    Heart Rhythm; 2016 Apr; 13(4):964-72. PubMed ID: 26681610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.
    Tsuji Y; Dobrev D
    Vasc Health Risk Manag; 2013; 9():165-75. PubMed ID: 23637539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs.
    Allessie MA; Wijffels MC; Dorland R
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S69-77. PubMed ID: 9727679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Acetylcholine-Activated Potassium Current Inhibitor XAF-1407 Terminates Persistent Atrial Fibrillation in Goats.
    Sobota V; Gatta G; van Hunnik A; van Tuijn I; Kuiper M; Milnes J; Jespersen T; Schotten U; Verheule S
    Front Pharmacol; 2020; 11():608410. PubMed ID: 33584287
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.